Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial

Journal:

The BMJ

Published:

2025-08-19

DOI:

10.1136/bmj-2025-085208

Affiliations:

20

Authors:

22

Go to article

Institutions	Authors	Share
Zhongda Hospital, SEU, China	2.000000	0.09
The First Affiliated Hospital, Zhejiang University School of Medicine, China	2.000000	0.09
Jiangxi Provincial People's Hospital, China	1.000000	0.05
Fourth Hospital of Hebei Medical University, China	1.000000	0.05
The Affiliated Hospital of Qingdao University, China	1.000000	0.05
Zhongshan Hospital of Dalian University, China	1.000000	0.05
Zhongshan Hospital of Traditional Chinese Medicine, China	1.000000	0.05
The First Affiliated Hospital of Nanchang University, China	1.000000	0.05
The First Affiliated Hospital of Xiamen University, China	1.000000	0.05
The First Hospital of China Medical University, China	1.000000	0.05
The First Affiliated Hospital of Henan University of Science and Technology, China	1.000000	0.05
Affiliated Hospital, Guizhou Medical University, China	1.000000	0.05
Wuxi People's Hospital, NJMU, China	1.000000	0.05
The First People's Hospital of Nanning, China	1.000000	0.05
The Second People's Hospital of Yibin, China	1.000000	0.05
The First People Hospital of Yueyang, China	1.000000	0.05
Zhongshan Hospital of Xiamen University, China	1.000000	0.05
First Hospital Affiliated to Baotou Medical College, IMUST, China	1.000000	0.05
Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital (SAMSPH), China	1.000000	0.05
Haisco, China	1.000000	0.05

Interested in Clinical Sciences?